Shareholders Turn Down Tender Offer to Take BioCanCell Private Post author:Sam Post published:December 27, 2017 Post category:BioPharma Approximately 5.9 million shares were necessary for the tender to be accepted. Source: BioSpace You Might Also Like Elite Pharma Reports Financial Results For The Fiscal Year Ended March 31, 2017 And Provides Conference Call Information June 14, 2017 Takeda Axes Sales Jobs, Forces Hundreds of Employees to Relocate to Boston July 17, 2017 Arix Bioscience, Takeda Partner Up to Create and Grow Biotechs March 1, 2017
Elite Pharma Reports Financial Results For The Fiscal Year Ended March 31, 2017 And Provides Conference Call Information June 14, 2017
